Status:
UNKNOWN
Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
Lead Sponsor:
Odense University Hospital
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-65 years
Brief Summary
Type 2 diabetes is a disorder of the metabolic system that greatly affects individual health and imposes significant cost for society on health care. It is necessary to initiate research with emphasis...
Eligibility Criteria
Inclusion
- Of diabetic subjects:
- Type 2 diabetes
- Age: 30-65 years
- BMI: 27-35
- Of nondiabetic subjects:
- Age: 30-65 years
- BMI: 27-35
Exclusion
- Of diabetic subjects:
- Medication, which have any influence on glucose metabolism and gene expression in adipose tissue and skeletal muscle at the time of sampling of biopsies.
- Disease in liver, heart, vessels or endocrine organs
- Of nondiabetic subjects:
- Type 2 diabetes
- Relatives with type 2 diabetes
- Hyperglycemia
- Medication, which have any influence on glucose metabolism and gene expression in adipose tissue and skeletal muscle at the time of sampling of biopsies.
- Disease in liver, heart, vessels or endocrine organs
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00143013
Start Date
October 1 2004
End Date
April 1 2007
Last Update
June 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Biochemistry and Genetics, KKA
Odense C, Funen, Denmark, 5000